ECRG4
Augurin
Also known as: AUGN_HUMAN, augurin, C2orf40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H1Z8
- Gene
- ECRG4
- Ensembl
- ENSG00000119147
- Chromosome
- 2
- Canonical length
- 148 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Enables neuropeptide hormone activity. Involved in neuropeptide signaling pathway; positive regulation of hormone secretion; and vasopressin secretion. Located in apical plasma membrane; dense core granule; and extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
148 residues, UniProt reviewed canonical sequence.
>Q9H1Z8|ECRG4
1 MAASPARPAV LALTGLALLL LLCWGPGGIS GNKLKLMLQK REAPVPTKTK VAVDENKAKE
61 FLGSLKRQKR QLWDRTRPEV QQWYQQFLYM GFDEAKFEDD ITYWLNRDRN GHEYYGDYYQ
121 RHYDEDSAIG PRSPYGFRHG ASVNYDDYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ECRG4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 412 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 412 nTPM
- blood vessel: 180 nTPM
- stomach: 164 nTPM
- thyroid gland: 100 nTPM
- seminal vesicle: 96 nTPM
- pituitary gland: 95 nTPM
Single-cell type
- early spermatids: 1,214 nCPM
- breast myoepithelial cells: 885 nCPM
- respiratory ciliated cells: 590 nCPM
- pericytes: 419 nCPM
- late primary spermatocytes: 239 nCPM
- vascular smooth muscle cells: 239 nCPM
Immune cell
- naive CD4 T-cell: 8.5 nTPM
- naive CD8 T-cell: 7.2 nTPM
- memory CD4 T-cell: 2 nTPM
- total PBMC: 1.4 nTPM
- memory CD8 T-cell: 1.3 nTPM
- T-reg: 0.8 nTPM
Brain region
- choroid plexus: 467 nTPM
- midbrain: 46 nTPM
- spinal cord: 41 nTPM
- medulla oblongata: 33 nTPM
- hypothalamus: 27 nTPM
- hippocampal formation: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anaphase-promoting complex-dependent catabolic process
- cellular senescence
- central nervous system development
- G1 to G0 transition
- regulation of cell population proliferation
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Augurin
- Oesophageal cancer-related gene 4
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ECRG4 as an antibody target. Whether an autoantibody or antibody against ECRG4 could matter depends on whether native ECRG4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ECRG4 is annotated at the cell surface, where native ECRG4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ECRG4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...